Work

P-362 ID2 acts as a novel tumor suppressor in MM by inhibition of TCF3 transcriptional activity

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)01980-8

Authors: Tommaso Perini, Yao Yao, Jessica Fong Ng, Shuhui Deng, Anais Schavgoulidze, Moritz Binder, Ryan Young, Mei Knudson, Charles Epstein, Annamaria Gulla, Eugenio Morelli, Raphael Szalat, Mehmet Samur, Kenneth Anderson, Mariateresa Fulciniti, Nikhil Munshi

Institutions: University Hospital Heidelberg, Candiolo Cancer Institute, Moffitt Cancer Center, Dana-Farber Cancer Institute, Boston University, University of Miami, Sylvester Comprehensive Cancer Center, Harvard University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387003551

Cites:

Cited by:

Related to: 10